Astrocyte Announces Initiation of First-In-Human Phase 1 Study of the Promising Stroke and Traumatic Brain Injury Therapeutic, AST-004
GROTON, Conn.--(BUSINESS WIRE)--Astrocyte Pharmaceuticals Inc., a drug discovery and development company advancing novel cerebroprotective therapeutics for patients with brain injuries,...
Private Wellness Club Continuum Unlocks Final Membership Tier at West Village Flagship